FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17440311000001100: Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60363901000001112 Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60364001000001110 Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Is a Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Is a Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has active ingredient Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Breath activated powder inhaler false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Is a Seretide Accuhaler true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Is a Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) 60 dose Has AMP True Seretide 250 Accuhaler (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start